All News

Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is a single-inhaler triple therapy for the long-term, maintenance treatment of patients with chronic obstructive pulmonary disease.

With tremendous advancements related to hepatitis B treatment in the last few years, the other types of hepatitis viruses are often overlooked.

Secnidazole (Solosec) oral granules granted approval to treat bacterial vaginosis in adult women.

Findings may lead to future treatments for patients with psoriasis and psoriatic arthritis.

Variation in HPV15 E7 protein greatly decreases the risk of invasive cervical cancer.

Vertebral artery dissection can lead to blood clots that cause strokes.

Limited proportion of patients with chronic hepatitis C virus received antiviral treatment before the widespread use of direct-acting antivirals.

A compound from honeybees attacks harmful bacteria in a new way.

A newly-discovered molecule can induce programmed cell death in mesenchymal-like lung cancer cells.

Guidelines that limit dietary fat intake and encourage carbohydrate intake could be increasing the risk of overall mortality.

An antibody-immunotherapy combination shows promise against high-risk pediatric cancer.

Certain adjuvant chemotherapy regimens may lead to long-lasting peripheral neuropathy in breast cancer survivors.

This one piece of unlikely job advice has helped me tremendously throughout my career

We all want to learn more about psychology to better communicate with others, but we just don't have the time. Here is a summary of takeaways from the most influential psychologists in the field.

Medtronic's Intellis platform can record and track patient activity all day and is managed on the Samsung Galaxy Tab S2 tablet interface.

The FDA approval of this 5-nitroimidazole antimicrobial agent was supported by 2 studies of women with BV and an open label safety study, which found efficacy for single-dose secnidazole 2 g.

Top news of the day from across the health care landscape.

Study findings could lead to new treatment options for patients with IBD in the future.

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV).

Top news of the day from across the healthcare landscape.

Findings may provide new treatment options for Duchenne muscular dystrophy.

Blood tests show that Americans may deviate from prescription drug regimens.

A synthetic anticoagulant can significantly reduce the risk of drug contamination.

Zika virus may infect glioblastoma stem cells and prevent replication.

Adjuvant endocrine therapy can prevent cancer recurrence but can result in painful side effects.

Genome analysis revealed 16 new gene variants that increase the risk of type 2 diabetes and heart disease.

Biosimilars offer the potential to provide patients with less costly alternatives.

Grapefruit juice is not the only juice pharmacists should mention to patients.